br1016a
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 16, 2021 (NCT05102266)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05102903 | Phase 1 | Sep 23, 2021 | Boryung Pharmaceutical Company, Metro Hospital |
| NCT05102266 | Phase 1 | Sep 16, 2021 | Bestian Hospital, Boryung Pharmaceutical Company |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boryung Pharmaceutical Company | For profit | 2 | 2 | 1 | 2021 |
| Bestian Hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Metro Hospital | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1